Miriam Provost's Insider Trades & SAST Disclosures
Miriam Provost's most recent trade in Transmedics Group Inc was a trade of 3,597 Common Stock done at an average price of $38.5 . Disclosure was reported to the exchange on Dec. 13, 2023.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Miriam Provost.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Transmedics Group Inc | Provost Miriam | VP, Global Regulatory Affairs | Exercise or conversion of derivative security received from the company (such as an option) at price $ 38.46 per share. | 13 Dec 2023 | 3,597 | 27,540 (0%) | 0% | 38.5 | 138,341 | Common Stock |
| Transmedics Group Inc | Miriam Provost | VP, Global Regulatory Affairs | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Dec 2023 | 3,597 | 7,813 | - | - | Stock Option (Right to Buy) | |
| Transmedics Group Inc | Miriam Provost | VP, Global Regulatory Affairs | Sale of securities on an exchange or to another person at price $ 75.10 per share. | 13 Dec 2023 | 2,407 | 25,133 (0%) | 0% | 75.1 | 180,766 | Common Stock |
| Transmedics Group Inc | Miriam Provost | VP, Global Regulatory Affairs | Gift of securities by or to the insider at price $ 0.00 per share. | 13 Dec 2023 | 1,785 | 23,348 (0%) | 0% | 0 | Common Stock | |
| Transmedics Group Inc | Miriam Provost | VP, Global Regulatory Affairs | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Dec 2023 | 1,632 | 7,073 | - | - | Stock Option (Right to Buy) | |
| Transmedics Group Inc | Miriam Provost | VP, Global Regulatory Affairs | Exercise or conversion of derivative security received from the company (such as an option) at price $ 66.10 per share. | 13 Dec 2023 | 1,632 | 25,452 (0%) | 0% | 66.1 | 107,875 | Common Stock |
| Transmedics Group Inc | Miriam Provost | VP, Global Regulatory Affairs | Sale of securities on an exchange or to another person at price $ 75.10 per share. | 13 Dec 2023 | 1,509 | 23,943 (0%) | 0% | 75.1 | 113,326 | Common Stock |
| Transmedics Group Inc | Provost Miriam | VP, Global Regulatory Affairs | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Dec 2023 | 415 | 7,811 | - | - | Stock Option (Right to Buy) | |
| Transmedics Group Inc | Miriam Provost | VP, Global Regulatory Affairs | Exercise or conversion of derivative security received from the company (such as an option) at price $ 16.14 per share. | 13 Dec 2023 | 415 | 24,026 (0%) | 0% | 16.1 | 6,698 | Common Stock |
| Transmedics Group Inc | Provost Miriam | VP, Global Regulatory Affairs | Sale of securities on an exchange or to another person at price $ 75.10 per share. | 13 Dec 2023 | 206 | 23,820 (0%) | 0% | 75.1 | 15,471 | Common Stock |
| Transmedics Group Inc | Miriam Provost | VP, Global Regulatory Affairs | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2023 | 8,705 | 8,705 | - | - | Stock Option (Right to Buy) | |
| Transmedics Group Inc | Miriam Provost | VP, Global Regulatory Affairs | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2023 | 5,685 | 20,839 (0%) | 0% | 0 | Common Stock | |
| Transmedics Group Inc | Miriam Provost | VP, Global Regulatory Affairs | Exercise or conversion of derivative security received from the company (such as an option) at price $ 38.46 per share. | 13 Dec 2022 | 5,918 | 19,469 (0%) | 0% | 38.5 | 227,606 | Common Stock |
| Transmedics Group Inc | Miriam Provost | VP, Global Regulatory Affairs | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Dec 2022 | 5,918 | 15,105 | - | - | Stock Option (Right to Buy) | |
| Transmedics Group Inc | Miriam Provost | VP, Global Regulatory Affairs | Sale of securities on an exchange or to another person at price $ 62.24 per share. | 13 Dec 2022 | 2,695 | 16,774 (0%) | 0% | 62.2 | 167,737 | Common Stock |
| Transmedics Group Inc | Miriam Provost | VP, Global Regulatory Affairs | Sale of securities on an exchange or to another person at price $ 63.00 per share. | 13 Dec 2022 | 1,620 | 15,154 (0%) | 0% | 63 | 102,060 | Common Stock |
| Transmedics Group Inc | Miriam Provost | VP, Global Regulatory Affairs | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Sep 2022 | 3,977 | 21,023 | - | - | Stock Option (Right to Buy) | |
| Transmedics Group Inc | Miriam Provost | VP, Global Regulatory Affairs | Exercise or conversion of derivative security received from the company (such as an option) at price $ 38.46 per share. | 02 Sep 2022 | 3,977 | 16,015 (0%) | 0% | 38.5 | 152,955 | Common Stock |
| Transmedics Group Inc | Miriam Provost | VP, Global Regulatory Affairs | Sale of securities on an exchange or to another person at price $ 59.00 per share. | 02 Sep 2022 | 3,046 | 12,969 (0%) | 0% | 59 | 179,714 | Common Stock |
| Transmedics Group Inc | Miriam Provost | VP, Global Regulatory Affairs | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Sep 2022 | 2,600 | 18,281 | - | - | Stock Option (Right to Buy) | |
| Transmedics Group Inc | Miriam Provost | VP, Global Regulatory Affairs | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.22 per share. | 02 Sep 2022 | 2,600 | 12,038 (0%) | 0% | 3.2 | 8,372 | Common Stock |
| Transmedics Group Inc | Miriam Provost | VP, Global Regulatory Affairs | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Sep 2022 | 1,149 | 8,226 | - | - | Stock Option (Right to Buy) | |
| Transmedics Group Inc | Miriam Provost | VP, Global Regulatory Affairs | Exercise or conversion of derivative security received from the company (such as an option) at price $ 16.14 per share. | 02 Sep 2022 | 1,149 | 14,118 (0%) | 0% | 16.1 | 18,545 | Common Stock |
| Transmedics Group Inc | Miriam Provost | VP, Global Regulatory Affairs | Sale of securities on an exchange or to another person at price $ 59.00 per share. | 02 Sep 2022 | 567 | 13,551 (0%) | 0% | 59 | 33,453 | Common Stock |
| Transmedics Group Inc | Miriam Provost | VP of Global Regl. Affairs | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2022 | 38,000 | 38,000 | - | - | Stock Option (Right to Buy) | |
| Transmedics Group Inc | Miriam Provost | VP of US Regulatory & FDA Rel. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Dec 2021 | 884 | 20,881 | - | - | Stock Option (Right to Buy) | |
| Transmedics Group Inc | Miriam Provost | VP of US Regulatory & FDA Rel. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.22 per share. | 23 Dec 2021 | 884 | 9,438 (0%) | 0% | 3.2 | 2,846 | Common Stock |
| Transmedics Group Inc | Miriam Provost | VP of US Regulatory & FDA Rel. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Sep 2021 | 5,625 | 9,375 | - | - | Stock Option (Right to Buy) | |
| Transmedics Group Inc | Miriam Provost | VP of US Regulatory & FDA Rel. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 16.14 per share. | 15 Sep 2021 | 5,625 | 12,431 (0%) | 0% | 16.1 | 90,788 | Common Stock |
| Transmedics Group Inc | Miriam Provost | VP of US Regulatory & FDA Rel. | Sale of securities on an exchange or to another person at price $ 31.34 per share. | 15 Sep 2021 | 3,877 | 8,554 (0%) | 0% | 31.3 | 121,505 | Common Stock |
| Transmedics Group Inc | Miriam Provost | VP of US Regulatory & FDA Rel. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jul 2021 | 2,206 | 21,765 | - | - | Stock Option (Right to Buy) | |
| Transmedics Group Inc | Miriam Provost | VP of US Regulatory & FDA Rel. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.22 per share. | 30 Jul 2021 | 2,206 | 6,806 (0%) | 0% | 3.2 | 7,103 | Common Stock |
| Transmedics Group Inc | Miriam Provost | VP of US Regulatory & FDA Rel. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2021 | 25,000 | 25,000 | - | - | Stock Option (Right to Buy) | |
| Transmedics Group Inc | Miriam Provost | VP of US Regulatory & FDA Rel. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Dec 2020 | 4,600 | 23,971 | - | - | Stock Option (Right to Buy) | |
| Transmedics Group Inc | Miriam Provost | VP of US Regulatory & FDA Rel. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.22 per share. | 11 Dec 2020 | 4,600 | 4,600 (0%) | 0% | 3.2 | 14,812 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges